上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.com

人 IL-36β 定量分析酶联免疫检测试剂盒

本试剂盒仅供科研使用
。用于体外定量检测人血清
、血浆或细胞培养上清液中的 IL-36β 浓度
。

使用前请仔细阅读说明书并检查试剂组分是否完整, 如有疑问请与我司联系，尊龙凯时人生就是搏将提供力所能及的帮助
。

IL-36β 简介

：

白介 36 贝塔（IL-36β ），是 11 个蛋白的白介 1 蛋白家族一个成员。人的 IL-36β 由 157 个氨基酸构成
，没有经典的信号肽
，由 C 末

端的 70 个氨基酸的不同，分两个亚型

，IL-36β 1 和 IL-36β 2 。IL-36β 1 缺少 IL－1 家族蛋白的四个保守β 折叠结构
。而 IL-36β 2 与相

应的小鼠




，狗，牛及马的 IL-36β 分别只有 62%
、 67%
、63%和 59%的相似性
。

IL-36β 一般由角化细胞

，幼稚 CD4+细胞
，神经元细胞及神经胶质细胞产生表达

。IL-36β 具有一般细胞因子的常见功能
，IL-36β 还

能作为

，幼稚 CD4+细胞及骨基质的树突状细胞的迁移诱导剂

。IL-36β 能诱导骨基质的树突状细胞产生包括 IL-12, IL-1β , IL-6 和 TNF-α

等炎性因子


。此外
，IL-36β 能协 IL-12 增强 Th1 型细胞的极化。在角化细胞的培养中
，IL-36β 能诱导巨噬细胞


、T 细胞和神经细胞等产

生大量的细胞因子和抗菌肽，包括 HBD-2, HBD-3, lipocalin 2, CAMP, elafin, serpinB1 和 IL-8 等。此外
，在角化细胞培养中
，还观

察到 MMP9 和 MMP19 的 mRNA 的表达上调。

检测原理:

本试剂盒采用双抗体夹心ELISA法检测样本中IL-36β 的浓度。IL-36β 捕获抗体已预包被于酶标板上


，当加入标本或参考品时，其中的

IL-36β会与捕获抗体结合


，其它游离的成分通过洗涤的过程被除去。当加入生物素化的抗人IL-36β 抗体后，抗人IL-36β 抗体与IL-36β 接

合

，形成夹心的免疫复合物
，其它游离的成分通过洗涤的过程被除去
。随后加入辣根过氧化物酶标记的亲合素

。生物素与亲合素特异性结

合，亲合素连接的酶就会与夹心的免疫复合物连接起来
；其它游离的成分通过洗涤的过程被除去
。最后加入显色剂


，若样本中存在IL-36β

将会形成免疫复合物，辣根过氧化物酶会催化无色的显色剂氧化成蓝色物质
，在加入终止液后呈黄色。通过酶标仪检测


，读其450nm处的OD

值

，IL-36β 浓度与OD450值之间呈正比
，通过参考品绘制标准曲线

，对照未知样本中OD值
，即可算出标本中IL-36β 浓度。

人IL-36β 定量分析酶联免疫检测试剂盒组成:

组分 规格（96T/48T）

人IL-36β 预包被板 12条/6条

标准品稀释液 10ml/5ml

人IL-36β 标准品 2支/1支(冻干)

人IL-36β 生物素化抗体 10ml/5ml

亲和素连接的HRP酶 10ml/5ml

浓缩洗涤液 20× 30ml/15ml

TMB底物 10ml/5ml

中止液 5ml/3ml

封板胶纸 3/2张

说明书 1份

标本收集:

1.标本的收集请按下列流程进行操作；

A.细胞上清标本离心去除悬浮物后即可






；

B.血清标本应是自然凝固后
，取上清
，避免在冰箱中凝固血液
；

C.血浆标本
，推荐用EDTA的方法收集

D.若待测样本不能及时检测，标本收集后请分装，冻存于－20℃



，避免反复冻融。

2.血清标本不应添加任何防腐剂或抗凝剂

；3.标本应清澈透明，检测前样本中如有悬浮物应通过离心去除。

4.请勿使用溶血
，高血脂或污染的标本检测，否则结果将不准确
。

注意事项:

1.试剂盒请保存在2～8℃

。

2.浓缩洗涤液因在低温下可能有结晶

，请水浴加热使结晶完全溶解后再配制工作液
。

3.标准品复溶加样后，剩余部份请丢弃。

4.底物请勿接触氧化剂和金属



。

5.加样时
，请及时更换枪头


，避免交叉污染。

6.严禁混用不同批号的试剂盒组份
。

7.充分混匀对保证反应结果的准性很重要，在加液后请轻轻叩击边缘以保证混匀。

8.室温反应

，请严格控制在25～28℃。

9.洗涤过程是至关重要的
，洗涤不充分会使精确度下降并导致结果误差较大。

10.试验中标准品和样本检测时建议作双复孔。

11.加样过程中避免气泡的产生

。

12.血清和血浆标本的检测时

，检测抗体的孵育时间应适当延长。

检测前准备工作:

1.试剂盒自冰箱中取出后应置室温（25-28℃）平衡20分钟
；每次检测后剩余试剂请及时于2～8℃保存
。

2.将浓缩洗涤液用双蒸水或去离子水稀释(1份加19份水)

。

3.标准品:根据标签复溶体积加入标准品稀释液使IL-36β 终浓度达到800pg/ml

，室温反应，请严格控制在25～28℃，静置15~20分钟后轻轻

混悬（建议抽吸几次）待彻底溶解













，用标准品稀释液倍比梯度稀释后依次加入检测孔中
。（标准曲线取七个点，最高浓度为800 pg/ml,标

准品稀释液直接加入作为0浓度.）

洗涤方法:

自动洗板机或人工洗板
：每孔洗涤液为300ul
，注入与吸出间隔15-30秒。洗板5次


。最后一次洗板完成后将板倒扣着在厚吸水纸上用力拍干。

实验过程需自备的材料
：

1.不同规格的加样枪及相应的枪头；

2.酶标仪


；

3.自动洗板机；

4.去离子水或双蒸水

；

操作步骤:

1.通过计算并确定一次性实验所需的板条数，取出所需板条放置在框架内






，暂时用不到板条请放回铝箔袋密封，保存于4℃

。

2.建议设置本底较正孔



，即空白孔,设置方法为该孔只加TMB显色液和中止液


。每次实验均需做标准品对照并画出标准曲线




。

3.分别将标本或不同浓度标准品(100ul/孔)加入相应孔中

，用封板胶纸封住反应孔

，室温（25-28℃）孵育120分钟
。4.洗板5次，且最后一

次置厚吸水纸上拍干



。

5.加入生物素化抗体工作液(100ul/孔)。用封板胶纸封住反应孔
，室温（25-28℃）孵育60分钟
。

6.洗板5次
，且最后一次置厚吸水纸上拍干
。

7.加入HRP酶结合物工作液(100ul/孔)。用封板胶纸封住反应孔










，避光室温（25-28℃）孵育20分钟

。

8.洗板5次，且最后一次置厚吸水纸上拍干

。

9.加入显色剂TMB100ul/孔

，避光室温（25-28℃）孵育20分钟
。

10.加入中止液50ul/孔,混匀后即刻测量OD450值
。

上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.comhIL-36参考标准曲线

0

0.5

1

1.5

2

2.5

0 25 50 100 200 400 800

浓度(pg/ml)

O

D值

上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.com

结果判断:

1.复孔的值在20%的差异范围内结果才有效

，复孔的值平均后可作为测量值
。

2.每个标准品或标本的OD值应减去本底校正孔的OD值
。

3.手工绘制标准曲线


。以标准品浓度作横坐标，OD值作纵坐标

，以平滑线连接各标准品的坐标点
。通过标本的OD值可在标准曲线上查出其

浓度。

4.若标本 OD 值高于标准曲线上限，应适当稀释后重测，计算浓度时应乘以稀释倍数


。

典型数值和参考曲线

浓度pg/ml 典型OD值1 典型OD值2 OD平均值

0 0.074 0.0689 0.07145

25 0.213 0.212 0.2125

50 0.313 0.3084 0.3107

100 0.527 0.5062 0.5166

200 0.835 0.8065 0.82075

400 1.328 1.3101 1.31905

800 2.038 1.9721 2.00505

人IL-36Β 参考标准曲线

注意
：本图仅供参考
，应以同次试验标准品所绘标准曲线计算标本含量。

灵敏度


，特异性和重复性:

1.灵敏度



：多次重复结果表明，最小检出量为9.6pg/ml



。

2.特异性：与人的IL-36α 、IL-36γ 及小鼠的IL-36β 等没有交叉反应
。

3.重复性：板内

，板间变异系数均<10%.

参考文献:

1. Magne, D. et al. (2005) Arthritis Res. Ther. 8:R80.

2. Johnston, A. et al. (2011) J. Immunol. 186:2613.

3. Vigne, S. et al. (2011) Blood 118:5813.

4. Kumar, S. et al. (2000) J. Biol. Chem. 275:10308.

5. Vigne, S. et al. (2012) Blood 120:3478.

6. Gresnigt, M.S. and F.L. van de Veerdonk (2013) Semin. Immunol. 25:458.上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.com

ELISA Kit for the Quantitative Analysis of Human IL-36β

The human IL-36βELISA (enzyme-linked immunosorbent assay) kit is used for detection of human IL-36β in cell culture

supernatants,human serum and plasma.THE ELISA KIT IS FOR RESEARCH USE ONLY. Please read this instruction manual

carefully and check out the material provided before use, and you can contact with our company if any questions. You can enter our

website or call us for other aim.

Introduction

Interleukin36 beta (IL-36β)is a member of the IL1 family which includes 11 members proteins. The human IL-36βis a 157 aa protein which does

not have a canonical signal peptide or prosegment . human IL-36β have two isoforms that IL-36β1 and IL-36β2 , which differ in their C-terminal

70 aa. IL-36β1 lacks four of the conserved β -strands common to the IL1 family. Human IL-36β2 shares 62%, 67%, 63% and 59% aa identity with

the most similar isoforms of mouse, canine, bovine and equine IL-36β, respectively .

IL-36β is expressed by keratinocytes, naïve CD4+ T cells, neurons and glia . IL-36β functions as a chemokine and induces migration of bone

marrow-derived dendritic cells (BMDCs) and CD4+ T cells. IL-36β induces proinflammatory cytokines, including IL-12, IL-1β, IL-6, and TNF-α in

BMDCs. Furthermore, it has been shown that IL-36β synergizes with IL-12 to enhance Th1 polarization. In a cultured keratinocyte system, IL-36β

can induce robust expression of many chemokines in macrophages, T cells, and neutrophils. The secretion of antimicrobial peptides, including

HBD-2, HBD-3, lipocalin 2, CAMP, elafin, serpinB1, and IL-8 can be induced by IL-36β in keratinocytes in culture. IL-36β, can also upregulate

MMP9 and MMP19 mRNA in cultured keratinocytes.

Principles of the Test

The kits is a solid sandwich enzyme-linked immunosorbent assay for detection of human IL-36β . An anti-human IL-36β monoclonal

antibody has been absorbed onto the wells of the microtiter strips provided. Samples including specimens or standards were pipetted into

wells. The human IL-36β in specimens or standards would be captured by the coated antibody and the free others were removed by

washing. The human IL-36β biotin-conjugated antibody were added and binds to human IL-36β captured by the first antibody, which

formed a sandwich. Streptavidin-HRP would be added and binds to the biotin conjugated antibody, then free Streptavidin-HRP would be

removed during a wash step. After this, subtrate solution would be added and catalyzed by the HRP, and a coloured product is formed.

The intensity of the colored product is used to calculate in proportion to the amount of human IL-36β in the original specimen

Materials provided with the kits:

Reagent 96/48Test Kit

Human IL-36β Antibody-Coated Wells 12 strips/6 strips

Standard Diluent 10 ml/5ml

Human IL-36β Standard 2/1vial(s)

Human IL-36β Detetion Antibody 10ml/5ml

Streptavidin-HRP 10ml/5ml

Wash Buffer Concentrate 20× 30ml/15ml

TMB 10ml/5 ml

Stop Solution 5ml/3 ml

Plate Covers 3/2

Complete Instruction Manual 1

Specimen Collection

1. Collecting specimen as following:

A. The particulate of the cell culture supernatants should be removed before use.

B. Serum was obtained from clot at room temperature.

C. Please collect plasma with EDTA.D. Assay immediately or store samples at -20℃. Avoid free-thaw cycles.

2. Antiseptic and anticoagulant should not appear in Serum samples.

3. Any particulate should be removed from samples before use.

4. Do not use grossly hemolyzed or lipemic samples.

Precautions for use:

1. Please storage the Kit at 2～8℃
。

2. Washing buffer concentrate may have crystal in low temperature, and you can melt its in water-bath before use.

3. Please discard the remains after use of the dissolved standard.

4. Avoid contact of substrate solution with oxidizing agents and metal.

5. Usage of disposable pipette tips avoid microbial contamination or cross-contamination of reagents or specimens.

6. Do not mix or substitute reagents with those from other lots or other sources.

7. To ensure the adequate mixure of added reagents, please tap gently the plate after the wells were filled with liquid.

8. Incubation temperature should be 25～28℃.

9. Wash step was crucial for whole assay process.

10. Duplicate wells of the same sample were recommended in assay process.

11. Avoid the foam while pour the liquid into wells.

12. For serum or plasma samples ,the biotin-conjugated antibody should be incubate for at least 90 minutes.

Reagent Preparation

1.The reagents should be warmed up to room temperature before use. The remanent reagents must reseal and put into refrigeratory

again as soon as possible.

2.Dilute 1ml of wash buffer Concentrate into 19ml deionized or distilled water to work.

3. Add 0.4ml deionized or distilled water to bottle wait 15 minutes for complete dissolution. Incubation temperature should be 25～

28℃。.And in turn add the half concentration diluent by standard diluent .

Wash step:

Automated microplate washer or operating by pipette: Each well should be pour into300ul wash buffer and soak 15 or 30 seconds,then

be aspirated, five times process were repeated. After the last wash, remove remaining wash buffer by aspirating. Invert the plate and blot

it against clean paper towels.

Materials Required But Not Provided

1. pipettes and pipette tips

2. Microwell strip reader capable of reading at 450 nm (540 nm asoptional reference wave length)

3. automated microplate washer

4.Glass-distilled or deionized water

Assay procedure

1.The needed strips were putted into the frame, the remains were returned into foil pouch and resealed.

2.Blank well were recommended, which only color reagent and stop solution be added. It is suggested that each testing with gradient

density of standard for standard curve.

3.Add 100ul of standard or sample.Cover with the Plate Covers provided.Incubate for 2 hours at room temperature4.Five times wash

process were repeated.

5.Add 100ul of detetion antibody. Cover with the Plate Covers provided.Incubate for 1 hour at room temperature.

6.Five times wash process were repeated.

7.Add 100ul of Streptavidin-HRP. Cover with the Plate Covers provided. Lucifugal incubation for 20 minutes at room temperature.

8.Five times wash process were repeated.

9.Add 100ul of TMB








，Lucifugal incubation for 20 minutes at room temperature.

10.Add 50ul of stop solution to each well, determine the optical

density of each well within 10 minutes

Calculation of Results

上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.comhIL-36 Standard Curve

0

0.5

1

1.5

2

2.5

0 25 50 100 200 400 800

Concentration(pg/ml)

O

p

t

i

c

a

l

D

e

n

s

i

t

y

上海尊龙凯时人生就是搏生物科技有限公司 www.hualeizs.com

1.Duplicates should be within 20 percent of the mean. Average absorbance values for each set of duplicate samples were used as

detection results.

2.The blank absorbance values of subtract should be deducted.

3.Drawing a best fit curve through the points of graph. Draw the standard curve by plotting assayed OD valure (on the Y axis) vs.

concentration (on the X axis). The sample concentration was obtained based on its OD value founding in the standard concentration

curve.

4.If the values obtained are not within the expected range of the standard, Samples should be dilute and assay again.

Typical Data and Standard Curve

concentration (pg/ml) Typical data 1 Typical data 2 Average

0 0.074 0.0689 0.07145

25 0.213 0.212 0.2125

50 0.313 0.3084 0.3107

100 0.527 0.5062 0.5166

200 0.835 0.8065 0.82075

400 1.328 1.3101 1.31905

800 2.038 1.9721 2.00505

Human IL-36β Standard Curve

Sensitivity,Specificity, Repeatability

Sensitivity: repeated assays were evalsuated and the minimum detectable dose was 9.6pg/ml.

Specificity: No significant cross-reactivity or interference with human IL-36α ,IL-36γ and Mouse IL-36β .

Repeatability: The coefficient of variation between wells or plates is less than 10 per cent.

REFERENCES:

1. Magne, D. et al. (2005) Arthritis Res. Ther. 8:R80.

2. Johnston, A. et al. (2011) J. Immunol. 186:2613.

3. Vigne, S. et al. (2011) Blood 118:5813.

4. Kumar, S. et al. (2000) J. Biol. Chem. 275:10308.

5. Vigne, S. et al. (2012) Blood 120:3478.

6. Gresnigt, M.S. and F.L. van de Veerdonk (2013) Semin. Immunol. 25:458.